Addict Health. 2021 Oct;13(4):249-258. doi: 10.22122/ahj.v13i4.1238.

ABSTRACT

BACKGROUND: To provide prevention programs and educate drug users (DUs), the estimation of their population is necessary. This study aimed to estimate the population size of this hidden group in Isfahan city as a metropolitan in Iran using the network scale-up ýmethod (NSUM).

METHODS: This cross-sectional study was performed in summer 2018 on 1000 people selected through a multistage sampling method based on 14 region of the municipality of Isfahan. The data collection tool was a questionnaire that was previously used in Dr. Banshi’s national plan without any changes. The Cronbach’s alpha value of the questionnaire was 0.826. Using correction factors such as transparency of response and the ratio of social network size used in previous national studies, the number of people with high-risk behaviors was estimated. The results were analyzed through NSUM based on survey analysis.

FINDINGS: Among all kinds of DUs, men were the largest consumers. The prevalence of use of opium, cannabis, heroin/crack, stimulants, ecstasy, hallucinogens, tramadol, zolpidem, tobacco, and drug injection was 2983, 2342, 613, 766, 86, 268, 1185, 213, 5869, 135 in 100000 people, among individuals of over 18 years of age. In both sexes, the prevalence of using opium and its nectar and illegal treatment with methadone and buprenorphine was higher in people of over 30 years of age, while the prevalence of consuming cannabis, ecstasy, tramadol, tobacco products, and stimulants was higher in the age group of 18 to 30 years.

CONCLUSION: The results indicated that the prevalence of different DUs in Isfahan city, especially among men was higher than the reported average (especially in young men of 18-30 years of age). Since the prevalence of drug use varies based on the type of substance used among age groups, targeted preventive planning based on the type of drug used and age group is recommended.

PMID:35178197 | PMC:PMC8818311 | DOI:10.22122/ahj.v13i4.1238


Source: ncbi 2

Partage le savoir
Categories: Medical

error: Content is protected !!